Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-03-06
1993-08-24
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514211, 514212, 514217, 514216, 514220, 514219, 5142245, 5142258, 5142295, 5142298, 544 43, 544104, 544 37, 544102, 544207, 544212, 544198, 540575, 540598, 540460, 540461, 540468, 540469, 540471, 540479, 540488, 540489, 540495, 540522, 540548, 540549, 540547, 540545, 540557, 540590, C07D40104, C07D40106, C07D40112, C07D40304, C07D40306, C07D40514, C07D40312, A61K 3153
Patent
active
052389367
ABSTRACT:
The compounds are trisubstituted triazines and pyrimidines useful for the suppressing the resistance of tumour cells to anti-cancer agents and for suppressing the resistance of parasites to anti-parasitic agents.
A compound disclosed is 2,4-diallylamino-6-{4-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl) methylamino]piperidin-1-yl}-1,3,5-triazine.
REFERENCES:
Hayashi et al., Chemical Abstracts, vol. 111, entry 25008g (1988).
Atassi Ghanem
Dhainaut Alain
Leonce Stephane
Pierre Alain
Regnier Gilbert
Adir et Compagnie
Ford John M.
Hueschen Gordon W.
LandOfFree
Trisubstituted triazines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trisubstituted triazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trisubstituted triazines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-829427